Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Oct;51(10):2678–2685. doi: 10.1172/JCI107086

Effects of Heparin and ε-Aminocaproic Acid in Dogs on Plasmin- 125I Generation in Response to Urokinase Injections and Venous Injury

Y Takeda 1, T R Parkhill 1, M Nakabayashi 1
PMCID: PMC332967  PMID: 4262519

Abstract

The isotopic method described previously for quantification of plasmin- 125I by disc gel electrophoresis was modified by inclusion of euglobulin precipitation to expand its applicability to plasmas containing low radioactivity of plasmin- 125I and plasminogen- 125I. It was found that the euglobulin precipitation method precipitates 72.4±2.1 (sd)% of both plasmin- 125I and plasminogen- 125I. Using this method and plasminogen- 125I as a tracer, studies were first made of the effects of heparin and ε-aminocaproic acid in dogs on plasmin- 125I generation in responese to a single injection of urokinase and to venous injury; second, of the effects of venous occlusion and thrombosis on plasmin- 125I generation; and third, in vitro studies of plasminogen- 125I affinity to fibrin and its activation in blood clots. The venous injury was produced by the damage of venous endothelium by an injection of 90% phenol and the thrombosis by a thrombin injection into an occluded vein. Heparin and ε-aminocaproic acid under the present experimental conditions inhibited about 78 and 100%, respectively of plasmin- 125I generation by the urokinase injection. Similar inhibitory effects of heparin and ε-aminocaproic acid were observed on plasmin- 125I generation in response to venous injury. The venous occlusion caused a small degree of plasmin- 125I generation, but thrombin thrombosis did not seem to stimulate the generation of plasmin- 125I. The in vitro studies showed that plasminogen- 125I does not have a specific affinity to fibrin and is incorporated into blood clots in approximately equal concentrations as those in serum during clotting processes, and that blood clots per se do not stimulate plasmin- 125I generation. These results suggest that injured veins release considerable amounts of vascular plasminogen activators into circulation and that these play an important role in thrombus dissolution in vivo.

Full text

PDF
2678

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. THE ASSAY OF UROKINASE PREPARATIONS FOR CONTAMINATION WITH THROMBOPLASTIC MOIETIES. J Lab Clin Med. 1965 May;65:732–738. [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  3. ASTRUP T., CROOKSTON J., MACINTYRE A. Proteolytic enzymes in blood. Acta Physiol Scand. 1950 Nov;21(2-3):238–249. doi: 10.1111/j.1748-1716.1950.tb00732.x. [DOI] [PubMed] [Google Scholar]
  4. Abiko Y., Iwamoto M., Tomikawa M. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor. Biochim Biophys Acta. 1969;185(2):424–431. doi: 10.1016/0005-2744(69)90435-5. [DOI] [PubMed] [Google Scholar]
  5. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  6. FLETCHER A. P., ALKJAERSIG N., SHERRY S., GENTON E., HIRSH J., BACHMANN F. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. J Lab Clin Med. 1965 May;65:713–731. [PubMed] [Google Scholar]
  7. GIACOMAZZI G. Influence de l'héparine sur la fibrinolyse activée par la streptokinase. Sang. 1958;29(7):614–619. [PubMed] [Google Scholar]
  8. HOLEMANS R., ADAMIS D., HORACE J. F. INTERACTION OF HEPARIN WITH FIBRINOLYSIS. Thromb Diath Haemorrh. 1963 Jul 15;143:446–458. [PubMed] [Google Scholar]
  9. Johnson A. J., Kline D. L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh. 1969 Apr 30;21(2):259–272. [PubMed] [Google Scholar]
  10. KLINE D. L. Studies on the purification and activation of plasminogen (profibrinolysin). Yale J Biol Med. 1954 Apr;26(5):365–371. [PMC free article] [PubMed] [Google Scholar]
  11. KONTTINEN Y. The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma. Scand J Clin Lab Invest. 1962;14:15–18. [PubMed] [Google Scholar]
  12. LACKNER H., MERSKEY C. Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin. Br J Haematol. 1960 Oct;6:402–413. doi: 10.1111/j.1365-2141.1960.tb06259.x. [DOI] [PubMed] [Google Scholar]
  13. SCHMIDHAUSER-KOPPM, EICHENBERGER E. Uber den Einfluss von Thrombin und Heparin auf die Fibrinolyse. Experientia. 1952 Sep 15;8(9):354–355. doi: 10.1007/BF02174416. [DOI] [PubMed] [Google Scholar]
  14. Takeda Y. Plasminogen- 125 I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury. J Clin Invest. 1972 Jun;51(6):1363–1377. doi: 10.1172/JCI106932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. VINAZZER H. Untersuchungen über die fibrinolytische Wirkung des Heparins. Wien Z Inn Med. 1951 Apr;32(4):167–173. [PubMed] [Google Scholar]
  16. VON KAULLA K. N. Antikoagulantien und Fibrinolyse. Medizinische. 1953 Dec 19;51:1651–1654. [PubMed] [Google Scholar]
  17. VON KAULLA K. N., McDONALD T. S. The effect of heparin on components of the human fibrinolytic system. Blood. 1958 Aug;13(8):811–821. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES